Peroxisome proliferator-activated receptor α antagonism inhibits hepatitis C virus replication

Chemistry and Biology

Volumn 13, Issue 1, 2006, Pages 23-30

  Rakic, Bojana ^a,b   Sagan, Selena M ^a   Noestheden, Matthew ^a,b   Bélanger, Sylvie ^a   Nan, Xiaolin ^c   Evans, Conor L ^c   Xie, X Sunney ^c   Pezacki, John Paul ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITRO N (PYRIDYL)BENZAMIDE; 2-CHLORO-5-NITRO-N-(PYRIDYL)BENZAMIDE; BENZAMIDE DERIVATIVE; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SMALL INTERFERING RNA;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS C VIRUS; HUMAN; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; VIRUS REPLICATION;

BENZAMIDES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HUMANS; LIPIDS; MOLECULAR STRUCTURE; PPAR ALPHA; RNA, SMALL INTERFERING; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 30744432858     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2005.10.006     Document Type: Article

References (54)

1. K.E. Reed, and C.M. Rice Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties Curr. Top. Microbiol. Immunol. 242 2000 55 84
2. C.B. Bigger, K.M. Brasky, and R.E. Lanford DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection J. Virol. 75 2001 7059 7066
3. A.P. McCaffrey, K. Hashi, L. Meuse, S.L. Shen, A.M. Lancaster, P.J. Lukavsky, P. Sarnow, and M.A. Kay Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice Mol. Ther. 5 2002 676 684
4. A. Wasley, and M.J. Alter Epidemiology of hepatitis C: geographic differences and temporal trends Semin. Liver Dis. 20 2000 1 16
5. D.W. Bradley Hepatitis viruses: their role in human cancer Proc. Assoc. Am. Physicians 111 1999 588 593
6. J.M.L. Christie, H. Chapel, R.W. Chapman, and W.M.C. Rosenberg Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus Hepatology 30 1999 1037 1044
7. M.J. Alter, H.S. Margolis, K. Krawczynski, F.N. Judson, A. Mares, W.J. Alexander, P.Y. Hu, J.K. Miller, M.A. Gerber, and R.E. Sampliner The natural-history of community-acquired hepatitis-C in the United States N. Engl. J. Med. 327 1992 1899 1905
8. L.E. Adinolfi, M. Gambardella, A. Andreana, M.F. Tripodi, R. Utili, and G. Ruggiero Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 2001 1358 1364
9. A.I. Su, J.P. Pezacki, L. Wodicka, A.D. Brideau, L. Supekova, R. Thimme, S. Wieland, J. Bukh, R.H. Purcell, and P.G. Schultz Genomic analysis of the host response to hepatitis C virus infection Proc. Natl. Acad. Sci. USA 99 2002 15669 15674
10. J. Ye, C.F. Wang, R. Sumpter, M.S. Brown, J.L. Goldstein, and M. Gale Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation Proc. Natl. Acad. Sci. USA 100 2003 15865 15870
11. D. Moradpour, R. Gosert, D. Egger, F. Penin, H.E. Blum, and K. Bienz Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex Antiviral Res. 60 2003 103 109
12. R. Gosert, D. Egger, V. Lohmann, R. Bartenschlager, H.E. Blum, K. Bienz, and D. Moradpour Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons J. Virol. 77 2003 5487 5492
13. K. Moriya, H. Yotsuyanagi, Y. Shintani, H. Fujie, K. Ishibashi, Y. Matsuura, T. Miyamura, and K. Koike Hepatitis C virus core protein induces hepatic steatosis in transgenic mice J. Gen. Virol. 78 1997 1527 1531
14. R.G. Hope, and J. McLauchlan Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein J. Gen. Virol. 81 2000 1913 1925
15. S.T. Shi, S.J. Polyak, H. Tu, D.R. Taylor, D.R. Gretch, and M.M.C. Lai Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins Virology 292 2002 198 210
16. U. Pfeifer, R. Thomssen, K. Legler, U. Bottcher, W. Gerlich, E. Weinmann, and O. Klinge Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 33 1980 233 243
17. P. Friebe, J. Boudet, J.P. Simorre, and R. Bartenschlager Kissing-loop interaction in the 3′ end of the hepatitis C virus genome essential for RNA replication J. Virol. 79 2005 380 392
18. D. Moradpour, V. Brass, E. Bieck, P. Friebe, R. Gosert, H.E. Blum, R. Bartenschlager, F. Perlin, and V. Lohmann Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication J. Virol. 78 2004 13278 13284
19. I. Issemann, and S. Green Activation of a member of the steroid-hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
20. D. Auboeuf, J. Rieusset, L. Fajas, P. Vallier, V. Frering, J.P. Riou, P. Staels, J. Auwerx, M. Laville, and H. Vidal Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: no alteration in adipose tissue of obese and NIDDM patients Diabetes 46 1997 1319 1327
21. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, and R.M. Evans Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors Nature 358 1992 771 774
22. R. Hertz, J. Bisharashieban, and J. Bartana Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III J. Biol. Chem. 270 1995 13470 13475
23. G. Lee, F. Elwood, J. McNally, J. Weiszmann, M. Lindstrom, K. Amaral, M. Nakamura, S. Miao, P. Cao, and R.M. Learned T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities J. Biol. Chem. 277 2002 19649 19657
24. M.T. Nakamura, Y. Cheon, Y. Li, and T.Y. Nara Mechanisms of regulation of gene expression by fatty acids Lipids 39 2004 1077 1083
25. S. Mandard, M. Muller, and S. Kersten Peroxisome proliferator-activated receptor α target genes Cell. Mol. Life Sci. 61 2004 393 416
26. S.A. Kliewer, S.S. Sundseth, S.A. Jones, P.J. Brown, G.B. Wisely, C.S. Koble, P. Devchand, W. Wahli, T.M. Willson, and J.M. Lenhard Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proc. Natl. Acad. Sci. USA 94 1997 4318 4323
27. J.M. Lehmann, L.B. Moore, T.A. Smitholiver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high-affinity ligand for peroxisome proliferator-activated receptor γ(Ppar-γ) J. Biol. Chem. 270 1995 12953 12956
28. L. Everett, A. Galli, and D. Crabb The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease Liver 20 2000 191 199
29. H.E. Xu, M.H. Lambert, V.G. Montana, K.D. Plunket, L.B. Moore, J.B. Collins, J.A. Oplinger, S.A. Kliewer, R.T. Gampe, and D.D. McKee Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors Proc. Natl. Acad. Sci. USA 98 2001 13919 13924
30. H.E. Xu, T.B. Stanley, V.G. Montana, M.H. Lambert, B.G. Shearer, J.E. Cobb, D.D. McKee, C.M. Galardi, K.D. Plunket, and R.T. Nolte Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR α Nature 415 2002 813 817
31. R.T. Nolte, G.B. Wisely, S. Westin, J.E. Cobb, M.H. Lambert, R. Kurokawa, M.G. Rosenfeld, T.M. Willson, C.K. Glass, and M.V. Milburn Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ Nature 395 1998 137 143
32. W.R. Oliver, J.L. Shenk, M.R. Snaith, C.S. Russell, K.D. Plunket, N.L. Bodkin, M.C. Lewis, D.A. Winegar, M.L. Sznaidman, and M.H. Lambert A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport Proc. Natl. Acad. Sci. USA 98 2001 5306 5311
33. S. Kersten, J. Seydoux, J.M. Peters, F.J. Gonzalez, B. Desvergne, and W. Wrahli Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting J. Clin. Invest. 103 1999 1489 1498
34. Y.J.Y. Wan, Y. Cai, W. Lungo, P. Fu, J. Locker, S. French, and H.M. Sucov Peroxisome proliferator-activated receptor α-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice J. Biol. Chem. 275 2000 28285 28290
35. A. Yamaguchi, S. Tazuma, T. Nishioka, W. Ohishi, H. Hyogo, S. Nomura, and K. Chayama Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver Dig. Dis. Sci. 50 2005 1361 1371
36. S. Dharancy, M. Malapel, G. Perlemuter, T. Roskams, Y. Cheng, L. Dubuquoy, P. Podevin, F. Conti, V. Canva, and D. Philippe Impaired expression of the peroxisome proliferator-activated receptor α during hepatitis C virus infection Gastroenterology 128 2005 334 342
37. R. Bartenschlager, and V. Lohmann Novel cell culture systems for the hepatitis C virus Antiviral Res. 52 2001 1 17
38. M. Frese, V. Schwarzle, K. Barth, N. Krieger, V. Lohmann, S. Mihm, O. Haller, and R. Bartenschlager Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs Hepatology 35 2002 694 703
39. Sagan, S.M., Rouleau, Y., Leggiadro, C., Supekova, L., Schultz, P.G., Su, A.I., and Pezacki, J.P. (2006). The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication. Biochem. Cell Biol., in press.
40. M. Guzman, J.P. Cortes, and J. Castro Effects of lovastatin on hepatic fatty-acid metabolism Lipids 28 1993 1087 1093
41. J.X. Cheng, and X.S. Xie Coherent anti-Stokes Raman scattering microscopy: instrumentation, theory, and applications J. Phys. Chem. B 108 2004 827 840
42. X.L. Nan, J.X. Cheng, and X.S. Xie Vibrational imaging of lipid droplets in live fibroblast cells with coherent anti-Stokes Raman scattering microscopy J. Lipid Res. 44 2003 2202 2208
43. C.L. Evans, E.O. Potma, M. Pouris'haag, D. Côté, C.P. Lin, and X.S. Xie Chemical imaging of tissue in vivo with video-rate coherent anti-Stokes Raman Scattering microscopy Proc. Natl. Acad. Sci. USA 102 2005 16807 16812
44. K. Schoonjans, B. Staels, and J. Auwerx Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression J. Lipid Res. 37 1996 907 925
45. S. Reigadas, M. Ventura, L. Sarih-Cottin, M. Castroviejo, S. Litvak, and T. Astier-Gin HCV RNA-dependent RNA polymerase replicates in vitro the 3′ terminal region of the minus-strand viral RNA more efficiently than the 3′ terminal region of the plus RNA Eur. J. Biochem. 268 2001 5857 5867
46. Y. Takigawa, M. Nagano-Fujii, L. Deng, R. Hidajat, M. Tanaka, H. Mizuta, and H. Hotta Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome Microbiol. Immunol. 48 2004 591 598
47. S.T. Shi, K.J. Lee, H. Aizaki, S.B. Hwang, and M.M.C. Lai Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that coffactionates with caveolin-2 J. Virol. 77 2003 4160 4168
48. T.C. McCarthy, P.T. Pollak, E.A. Hanniman, and C.J. Sinal Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-α target gene activation J. Pharmacol. Exp. Ther. 311 2004 864 873
49. R.T. Miller, S.E. Glover, W.S. Stewart, J.C. Corton, J.A. Popp, and R.C. Cattley Effect on the expression of c-met, c-myc and PPAR-α in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643 Carcinogenesis 17 1996 1337 1341
50. S.P. Anderson, C. Dunn, A. Laughter, L. Yoon, C. Swanson, T.M. Stulnig, K.R. Steffensen, R.A.S. Chandraratna, J.A. Gustafsson, and J.C. Corton Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver Mol. Pharmacol. 66 2004 1440 1452
51. S.P. Anderson, L. Yoon, E.B. Richard, C.S. Duan, R.C. Cattley, and J.C. Corton Delayed liver regeneration in peroxisome proliferator-activated receptor-α-null mice Hepatology 36 2002 544 554
52. T. Hashimoto, W.S. Cook, C. Qi, A.V. Yeldandi, J.K. Reddy, and M.S. Rao Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting J. Biol. Chem. 275 2000 28918 28928
53. S.B. Kapadia, and F.V. Chisari Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids Proc. Natl. Acad. Sci. USA 102 2005 2561 2566
54. S. Grimbert, D. Pessayre, C. Degott, and J.P. Benhamou Acute hepatitis induced by Hmg-Coa reductase inhibitor, lovastatin Dig. Dis. Sci. 39 1994 2032 2033